{
"id":"mk19_b_pm_s11",
"subspecialtyId":"pm",
"title":"Principles of Critical Care",
"jsonContent":{
"type":"section",
"id":"mk19_b_pm_s11",
"title":{
"__html":"Principles of Critical Care"
},
"titleNode":{
"type":"section-title",
"hlId":"809df5",
"children":[
"Principles of Critical Care"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_pm_s11_1",
"title":{
"__html":"Comprehensive Support of Critically Ill Patients"
},
"titleNode":{
"type":"section-title",
"hlId":"ebcdb0",
"children":[
"Comprehensive Support of Critically Ill Patients"
]
},
"children":[
{
"type":"p",
"hlId":"9c27af",
"children":[
"Critical care teams often include pharmacists, respiratory therapists, physical or occupational therapists, advanced practice providers, case managers, and social workers in addition to nurses and physicians. The goals of care are generally to restore health and allow the patient to return home while minimizing time in the hospital, medical complications, and long-term effects of critical illness. In cases of overwhelming or irreversible disease, goals of care may change to providing comfort and dignity at the end of life."
]
},
{
"type":"p",
"hlId":"32a75b",
"children":[
"Patients in the ICU are at risk of developing many hospital-acquired conditions. The most common are health care–associated infections, skin and soft tissue pressure injury, malnutrition, gastrointestinal bleeding, delirium, and weakness (see ",
{
"type":"cross-reference",
"target":"mk19_a_id_s17",
"children":[
"MKSAP 19 Infectious Disease"
]
},
" for information on health care–associated infections). Protocolized care can improve safety and decrease the incidence of these conditions."
]
},
{
"type":"p",
"hlId":"0422a1",
"children":[
"Protocols used in the ICU should be evidence-based and periodically reviewed to ensure accuracy. For instance, stress ulcer prophylaxis with acid suppression has been standard practice for all patients receiving mechanical ventilation. Randomized trials evaluating acid suppression compared with placebo in patients who are at risk found decreased incidence of clinically significant bleeding, but no difference in mortality. There was no difference in the incidence of pneumonia or ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Clostridioides difficile"
]
},
" infection. To this effect, practice guidelines give a weak recommendation to stress ulcer prophylaxis in those at high risk (i.e., patients with coagulopathy or chronic liver disease or who are receiving mechanical ventilation)."
]
},
{
"type":"p",
"hlId":"9dc03a",
"children":[
"The complexity of disease and interventions in a critically ill patient requires a methodical approach to daily care such as the organ system–based approach, which allows caregivers to review the main disease process, affected organs and systems, and related interventions."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_1",
"title":{
"__html":"Sedation and Analgesia"
},
"titleNode":{
"type":"section-title",
"hlId":"3ca104",
"children":[
"Sedation and Analgesia"
]
},
"children":[
{
"type":"p",
"hlId":"79a1ad",
"children":[
"ICU patients often require sedation and analgesia. The need for analgesia should be monitored at least every 4 hours. Pain should be assessed using an objective scale. ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t43",
"wrapId":"1",
"children":[
"Table 43"
]
}
]
},
" outlines current guideline recommendations for analgesia and sedation, emphasizing multimodal therapy to manage pain. Opiates remain the mainstay, yet concurrent interventions can reduce medication doses and improve pain control. Preemptive analgesia should be provided for painful procedures (e.g., arterial line, thoracostomy tubes)."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_pm_t43"
]
},
{
"type":"p",
"hlId":"9d99ba",
"children":[
"Sedation is commonly needed during invasive mechanical ventilation. Similar to analgesia, it requires monitoring and should be objectively assessed using a scale (e.g., Richmond Agitation Sedation Scale). Guidelines favor light sedation, often achieved with intermittent use of opiates. In patients who require continuous sedation, propofol or dexmedetomidine are preferred to benzodiazepines (associated with increased delirium). An evidence-based practice for correction of oversedation is to stop the drug until the level of sedation is appropriate and then restart it at half the previous dose."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_1_1",
"title":{
"__html":"Interruption of Sedation and Analgesia"
},
"titleNode":{
"type":"section-title",
"hlId":"e225c5",
"children":[
"Interruption of Sedation and Analgesia"
]
},
"children":[
{
"type":"p",
"hlId":"b29aaf",
"children":[
"Daily protocolized interruption of sedation and analgesia in critically ill patients is associated with decreased length of mechanical ventilation, length of ICU stay, and incidence of delirium, although possibly no difference in 90-day mortality. Protocolized light sedation has shown similar patient outcomes to daily sedation interruption."
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_1_2",
"title":{
"__html":"Delirium"
},
"titleNode":{
"type":"section-title",
"hlId":"e555ca",
"children":[
"Delirium"
]
},
"children":[
{
"type":"p",
"hlId":"4dbec8",
"children":[
"Delirium is characterized by an acute change in cognitive functioning over hours to days, with fluctuations during the course of the day. Features of delirium include inattention, disorganized thinking, executive dysfunction (difficulty with problem solving), altered level of consciousness (lethargy or hypervigilance), perceptual disturbances (hallucinations or delusions), altered psychomotor activity (hyperactivity, hypoactivity, or both), sleep-wake disturbances, and labile mood. Delirium is extremely common in ICU patients and is associated with increased length of ICU stay, morbidity, mortality, and post–intensive care cognitive impairment. Risk factors for delirium include exposure to benzodiazepines, blood transfusion, preexisting dementia, older age, previous coma, pre-ICU surgery or trauma, and high severity of illness on ICU admission. Patients should be monitored and assessed using scales such as the Confusion Assessment Method-ICU or Intensive Care Delirium Screening Checklist. Measures to decrease delirium include early mobilization, preservation of nocturnal sleep, adequate pain management, orientation of the patient, removal of vascular and urethral catheters, provision of visual and hearing aids, and minimization of nonessential medications. Early mobilization in the earliest days of critical illness can be effective for treating and preventing delirium. Large randomized studies have failed to demonstrate the effectiveness of any medication to prevent or treat delirium. Use of antipsychotics are controversial, with no conclusive evidence of benefit. Benzodiazepines should not be used unless they are needed to treat alcohol withdrawal or seizures. Treatment involves identification and correction of the underlying cause, multicomponent bundled interventions ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t44",
"wrapId":"2",
"children":[
"Table 44"
]
}
]
},
")"
]
},
", and maintaining adequate nutrition and hydration. For further discussion of delirium, see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s5_3",
"children":[
"MKSAP 19 Neurology"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_pm_t44"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"cc4dea",
"children":[
"Sedation and analgesia should be monitored using objective standardized scales."
]
},
{
"type":"keypoint",
"hlId":"c1e91f",
"hvc":true,
"children":[
"Benzodiazepines should not be used for treating delirium unless they are needed to treat alcohol withdrawal or seizures."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_2",
"title":{
"__html":"Nutritional Support"
},
"titleNode":{
"type":"section-title",
"hlId":"53fbbc",
"children":[
"Nutritional Support"
]
},
"children":[
{
"type":"p",
"hlId":"c961e2",
"children":[
"Malnutrition in critically ill patients leads to increased morbidity and mortality. All patients in the ICU should have a nutritional evaluation. Enteral nutrition should start within 24 to 48 hours of admission. Early enteral nutrition is associated with a decrease in mortality and infections. Enteral nutrition is preferred unless a contraindication is present (e.g., perforation, hemorrhage). Patients receiving vasopressors, neuromuscular blockers, hypothermia, or extracorporeal life support should receive enteral nutrition as soon as they can tolerate it. Critically ill patients who cannot maintain volitional nutritional intake should be fed as soon as possible using a gastric tube, large-bore tube, small-bore tube, or postpyloric tube. Guidelines recommend postpyloric feeding when a high risk for aspiration exists, but delays in placing a postpyloric tube should not delay initiation of enteral nutrition. Routine measurement of gastric residuals is not recommended because it delays achievement of feeding goals, increases the risk of clogging the enteral access, and may increase the risk for aspiration."
]
},
{
"type":"p",
"hlId":"e34eab",
"children":[
"Guidelines recommend that supplemental parenteral nutrition should be considered only after 7 to 10 days of meeting less than 60% of energy and protein requirements by the enteral route alone. Adding parenteral nutrition to supplement enteral nutrition before this period may lead to harm and should be avoided. In contrast, parenteral nutrition should be started as soon as possible for severely malnourished patients, those at high risk for malnutrition, and those for whom enteral nutrition is not possible."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"79b853",
"children":[
"Enteral nutrition is preferred and should be started within 24 to 48 hours of admission to the ICU."
]
},
{
"type":"keypoint",
"hlId":"a0e965",
"children":[
"In nonmalnourished patients, supplemental parenteral nutrition should be considered only after 7 to 10 days of meeting less than 60% of energy and protein requirements by the enteral route alone."
]
},
{
"type":"keypoint",
"hlId":"096a9a",
"hvc":true,
"children":[
"In patients receiving enteral feedings, measurement of gastric residuals is not recommended because it delays achievement of feeding goals, increases the risk of clogging the enteral access, and may increase the risk for aspiration."
]
},
{
"type":"keypoint",
"hlId":"dd4518",
"hvc":true,
"children":[
"Administration of parenteral nutrition to supplement enteral nutrition may lead to harm and should be avoided."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_3",
"title":{
"__html":"Early Mobilization"
},
"titleNode":{
"type":"section-title",
"hlId":"97f147",
"children":[
"Early Mobilization"
]
},
"children":[
{
"type":"p",
"hlId":"9c2d69",
"children":[
"Many factors contribute to weakness in critically ill patients, including immobility, disease, medications, and medical interventions. Immobility may result in muscular weakness, joint stiffness, pressure ulcers, osteoporosis, gastrointestinal dysmotility, and dysautonomia. Even a few days of immobility can have a prolonged effect on muscular strength; long-term follow-up of patients with critical illness demonstrates persistent weakness at 1 and 5 years. Mobilization and exercise are intuitive strategies to solve this problem, and although evidence is not yet conclusive, the risk/benefit analysis favors their application. Mobilization strategies consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness are associated with decreased length of ICU stay and hospital stay, decreased days receiving mechanical ventilation, and improvements in quality of life and functional status."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a3fe6c",
"children":[
"The use of early mobilization strategies decreases length of time in the ICU and hospital and improves functional status and quality of life."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_4",
"title":{
"__html":"ICU Care Bundles"
},
"titleNode":{
"type":"section-title",
"hlId":"763042",
"children":[
"ICU Care Bundles"
]
},
"children":[
{
"type":"p",
"hlId":"b05f8c",
"children":[
"An ICU care bundle is a series of interventions that have been shown to improve patient outcomes when used together. Bundles can help clinicians monitor patients and guide appropriate interventions. Three care bundles that apply to critical care are summarized in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t45",
"wrapId":"3",
"children":[
"Table 45"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_pm_t45"
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_5",
"title":{
"__html":"High Value Care in the ICU"
},
"titleNode":{
"type":"section-title",
"hlId":"75f17c",
"children":[
"High Value Care in the ICU"
]
},
"children":[
{
"type":"p",
"hlId":"58bcd5",
"children":[
"Critical care is responsible for a large proportion of U.S. health care costs. However, survival and quality-of-life outcomes are not that different from other top-economy countries. Societal, organizational, and payment pressures have encouraged a focus on providing high value care, defined as care that balances clinical benefit with cost and harm, with the goal of improving patient outcomes. The ICU is an environment in which high value care can have major effects, as the resources are expensive and the culture favors aggressive resource use. Internal medicine and critical care medical societies have joined the American Board of Internal Medicine Foundation's Choosing Wisely campaign to promote cost-effective strategies that improve patient care and avoid waste and harm. In 2021 the ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.choosingwisely.org/societies/society-of-critical-care-medicine/:",
"target":"_blank"
},
"children":[
"Society of Critical Care Medicine's Choosing Wisely"
]
},
" recommendations (1) retaining catheters and drains without a clear indication, (2) delaying discontinuation of mechanical ventilation, (3) continuing antibiotic therapy without need, (4) delaying mobilization of critically ill patients, and (5) providing care without ensuring that it aligns with patient preferences. The 2014 Choosing Wisely list included a recommendation against daily routine laboratory testing."
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_6",
"title":{
"__html":"Respiratory Support"
},
"titleNode":{
"type":"section-title",
"hlId":"188ed0",
"children":[
"Respiratory Support"
]
},
"children":[
{
"type":"p",
"hlId":"f97a77",
"children":[
"Admission to the ICU for respiratory insufficiency is prompted by three basic conditions: hypoxemic respiratory failure, hypercapnic respiratory (ventilatory) failure, and upper airway impairment."
]
},
{
"type":"p",
"hlId":"53a4ca",
"children":[
"Acute hypoxemic respiratory failure is caused by shunting (perfusion of lung units that are not ventilated) because of alveolar collapse or flooding with cells, fluid, or blood. Therapies for hypoxemia include increasing the inhaled oxygen concentration or applying positive end-expiratory pressure to open up flooded or collapsed alveoli."
]
},
{
"type":"p",
"hlId":"a485c0",
"children":[
"Acute hypercapnic respiratory failure is caused by dead space (ventilation of poorly perfused lung units) or pump failure (inability to move air in and out of the lungs). Adequate ventilation requires sufficient pressure from the respiratory muscles to move air to the alveoli. The pressure generated has to overcome both elastic (chest wall and lung) and resistive (airway) forces. Ventilatory failure can result from elastic and resistive forces that are too high or respiratory muscles that are too weak. Mechanical ventilation (invasive or noninvasive) is the mainstay treatment for hypercapnia."
]
},
{
"type":"p",
"hlId":"6fa0c7",
"children":[
"Upper airway impairment is usually a manifestation of either obstruction of the airway (e.g., angioedema) or inability to protect the airway (e.g., opiate intoxication). The management is to maintain a patent airway (e.g., endotracheal tube, tracheostomy, or cricothyrotomy) (see ",
{
"type":"cross-reference",
"target":"mk19_b_pm_s12_1_1",
"children":[
"Common ICU Conditions"
]
},
")."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_6_1",
"title":{
"__html":"Oxygen Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"bfe5a7",
"children":[
"Oxygen Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"a2f72b",
"children":[
"Several devices deliver oxygen, each with different characteristics that serve patients differently. These devices are titrated most often to maintain a “normal” arterial oxygen saturation (Sa",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
") or pulse oximetry (Sp",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"). However, higher oxygen saturation is not always desirable. Evidence now suggests that supplementing oxygen for patients whose oxygen saturation is already 96% or higher actually increases mortality. Recommendations include both that an Sp",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" of 96% or lower should be maintained in patients receiving oxygen therapy and that oxygen therapy should not be started for patients with acute myocardial infarction or stroke and an Sp",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" of 93% or higher. These guidelines do not apply to all acute medical conditions. For example, higher Sa",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" values are beneficial for patients with carbon monoxide poisoning (a specific case in which Sp",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" may be unreliable and Sa",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" should be used instead), cluster headache, sickle cell crisis, and pneumothorax."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_6_1_1",
"title":{
"__html":"High-Flow Nasal Cannula"
},
"titleNode":{
"type":"section-title",
"hlId":"4ace5d",
"children":[
"High-Flow Nasal Cannula"
]
},
"children":[
{
"type":"p",
"hlId":"38f834",
"children":[
"High-flow nasal mixes and humidifies high-flow air and oxygen (30 L/min or more) to deliver a consistent F",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"IO"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" (0.21-1.0) through a nasal cannula. The high flow creates some positive airway pressure, but the amount depends on the flow rate and cannot be quantified. High-flow nasal cannula can decrease respiratory rate, work of breathing, and dead space. It has physiological and patient comfort appeal, but the evidence is developing. Systematic reviews have found no difference in hypoxemic events compared with other methods used to oxygenate critically ill patients before and during intubation. In managing acute hypoxemic respiratory failure, it may decrease the need for tracheal intubation, but it has no demonstrated effect on patient mortality. Current guidelines recommend high-flow nasal cannula because the reduced risk for intubation is important to patients. In the postextubation period, high-flow oxygen may reduce the risk for recurrent respiratory failure and reintubation. In high-risk patients (older than 65 years or with chronic heart or lung disease), high flow alone was less effective than high flow plus noninvasive ventilation immediately after extubation in preventing reintubation."
]
},
{
"type":"p",
"hlId":"5b2b68",
"children":[
"The initial application of high-flow nasal cannula should occur in the critical care setting with close monitoring for tolerance and effectiveness. In patients with acute hypoxemic respiratory failure who are receiving high-flow oxygen, the ROX index, defined as the ratio of Sp",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"/F",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"IO"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" (%) to respiratory rate (breaths/min), is a validated score that helps identify patients at low or high risk for intubation."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7",
"title":{
"__html":"Mechanical Ventilatory Support: General Principles"
},
"titleNode":{
"type":"section-title",
"hlId":"3ba4da",
"children":[
"Mechanical Ventilatory Support: General Principles"
]
},
"children":[
{
"type":"p",
"hlId":"8f3bed",
"children":[
"Mechanical ventilator support for respiratory failure is accomplished by noninvasive positive pressure ventilation (NPPV), using a helmet, nasal, oral, or full-face mask, or invasive ventilation with an endotracheal tube or tracheostomy. Selection of NPPV or invasive ventilation is dependent on the clinical situation and the goals of treatment. Initiation of any form of mechanical ventilatory support should be performed in a monitored unit (emergency department or ICU)."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7_1",
"title":{
"__html":"Noninvasive Positive Pressure Ventilation"
},
"titleNode":{
"type":"section-title",
"hlId":"fedfd2",
"children":[
"Noninvasive Positive Pressure Ventilation"
]
},
"children":[
{
"type":"p",
"hlId":"08153b",
"children":[
"There are two types of NPPV: continuous positive airway pressure and bilevel positive airway pressure. Continuous positive airway pressure delivers a constant airway pressure during inspiration and expiration. Bilevel positive airway pressure delivers a higher level of positive airway pressure during inspiration than during expiration, thus providing additional inspiratory support and increased tidal volume. The support is titrated to an appropriate level of gas exchange and to optimize patient respiratory effort. ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t46",
"wrapId":"4",
"children":[
"Table 46"
]
}
]
},
" highlights the physiologic effects and indications for these different modes of ventilatory support."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_b_pm_t46"
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7_1_1",
"title":{
"__html":"Indications and Patient Selection"
},
"titleNode":{
"type":"section-title",
"hlId":"5d1930",
"children":[
"Indications and Patient Selection"
]
},
"children":[
{
"type":"p",
"hlId":"cc5048",
"children":[
"Evidence favors the use of NPPV in the critical care setting in patients with COPD exacerbations, cardiogenic pulmonary edema, neuromuscular disease, or obesity hypoventilation syndrome and in patients at high risk of failing extubation (e.g., those >65 years old or with heart failure or COPD). However, NPPV also increases the risk for mortality in some patients, such as those with COPD exacerbations who failed NPPV and require subsequent intubation. All patients placed on NPPV need to be monitored and reevaluated within 2 hours to determine whether the therapy is effective and whether adjustments are needed."
]
},
{
"type":"p",
"hlId":"9643e7",
"children":[
"There is evidence suggesting harm when intubation is delayed or when tidal volumes are too high because of NPPV. Contraindications to the use of NPPV include persistent altered mental status, increased airway secretions, emesis, gastric distention, airway obstruction, recent esophageal surgery, cardiac arrest, inability to protect the airway, facial trauma/surgery (including oral, nasal, or sinus), and patient intolerance of the mask."
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7_1_2",
"title":{
"__html":"Application"
},
"titleNode":{
"type":"section-title",
"hlId":"e49874",
"children":[
"Application"
]
},
"children":[
{
"type":"p",
"hlId":"1189ff",
"children":[
"Proper mask sizing and patient adaptation to the device are essential; these require time and coaching of the patient. The timing of NPPV is very important, as late application (impending respiratory failure) is associated both with the need for subsequent intubation and with worse outcomes. After initiation, patients should be closely monitored for tolerance and adverse effects (patient comfort, skin integrity, gastric distention, and eye irritation), effectiveness of the ventilatory parameters (tidal volumes and respiration rate), and clinical improvement (blood pH, respiration rate, oxygen saturation, and mental status)."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7_2",
"title":{
"__html":"Invasive Mechanical Ventilation"
},
"titleNode":{
"type":"section-title",
"hlId":"34f4d0",
"children":[
"Invasive Mechanical Ventilation"
]
},
"children":[
{
"type":"p",
"hlId":"c5c438",
"children":[
"Invasive mechanical ventilation involves the use of an endotracheal tube or tracheostomy to deliver positive pressure ventilation. The indications for invasive mechanical ventilation are hypoxemic or hypercapnic respiratory failure, contraindication to NPPV, and inability to protect the airway. The timing, the ventilation mode, and the settings depend on disease and patient factors ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t47",
"wrapId":"5",
"children":[
"Table 47"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_b_pm_t47"
]
},
{
"type":"p",
"hlId":"8bd81d",
"children":[
"The appropriate mode of invasive mechanical ventilation is chosen on the basis of mode characteristics that favor the prevailing clinical goal, based on the patient's disease and physiologic status. When safety is the priority, the settings focus on lung protective ventilation, meaning adequate minute ventilation and oxygenation while maintaining the lowest effective tidal volume and plateau pressure to prevent ventilator-induced lung injury (see ",
{
"type":"cross-reference",
"target":"mk19_b_pm_s12_1_4_1",
"children":[
"Common ICU Conditions"
]
},
"). Ventilator-induced lung injury can occur early or late in the course of ventilation and results from the overdistension of alveoli (“volutrauma”) or the collapse of alveoli with expiration (“atelectrauma”)."
]
},
{
"type":"p",
"hlId":"5ee46e",
"children":[
"When patients are awake and the risk for lung injury has decreased, the prevailing goal becomes comfort. Patient-ventilator interaction should be optimized to provide comfort using a mode that allows synchrony and adequate support. Considerations include the patient's respiratory muscle weakness or fatigue, the presence of acidosis, and level of sedation."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_7_2_1",
"title":{
"__html":"Weaning"
},
"titleNode":{
"type":"section-title",
"hlId":"3787d0",
"children":[
"Weaning"
]
},
"children":[
{
"type":"p",
"hlId":"5b32c3",
"children":[
"Patients should be liberated from mechanical ventilation as soon as possible. The concurrent use of daily awakening or targeted light sedation protocols and spontaneous breathing trials reduces mechanical ventilation time and mortality ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t48",
"wrapId":"6",
"children":[
"Table 48"
]
}
]
},
")"
]
},
". Daily spontaneous breathing trials assess the readiness to breathe unassisted. The current recommendation is to perform trials of at least 30 minutes and no more than 2 hours in length, using low levels of pressure support (≤8 cm H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"O) or a T-piece to identify patients who can be evaluated for extubation."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_b_pm_t48"
]
},
{
"type":"p",
"hlId":"190db6",
"children":[
"Synchronized intermittent mandatory ventilation is a mode of ventilation that combines mandatory and spontaneous breaths. It should not be used to wean patients from mechanical ventilation."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"81c332",
"children":[
"Spontaneous breathing trials of from 30 minutes to 2 hours using low levels of pressure support (8 cm H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"O or less) can identify patients who may be evaluated for extubation."
]
},
{
"type":"keypoint",
"hlId":"9d35cf",
"children":[
"The use of NPPV immediately after extubation can prevent extubation failure in patients at high risk, such as those with heart failure, COPD, or hypercapnia."
]
}
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_8",
"title":{
"__html":"Hemodynamic Support"
},
"titleNode":{
"type":"section-title",
"hlId":"4cf4bd",
"children":[
"Hemodynamic Support"
]
},
"children":[
{
"type":"p",
"hlId":"e92b32",
"children":[
"Patients in the ICU sometimes require invasive tools for hemodynamic monitoring. These devices increase the risk for adverse events, so they should be used only when sufficient information cannot be obtained with noninvasive methods and should be removed as soon as possible. For example, routine use of pulmonary artery catheters does not lead to improved outcomes, is associated with increased complications, and may increase mortality."
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_9",
"title":{
"__html":"Intravenous Access"
},
"titleNode":{
"type":"section-title",
"hlId":"f9e1d0",
"children":[
"Intravenous Access"
]
},
"children":[
{
"type":"p",
"hlId":"28b519",
"children":[
"There are several devices available to achieve central intravenous (IV) access. Use depends on many factors, including urgency, expected duration, and reason for access ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t49",
"wrapId":"7",
"children":[
"Table 49"
]
}
]
},
")"
]
},
". Peripheral venous access with a short, wide-bore catheter is the route of choice for rapid volume resuscitation. Removal of intraosseous devices should be done within 24 hours of placement. In general, all IV access should be removed as soon as possible to decrease the risk for infection or thrombosis. Procedure-related complications, such as arterial injury, nerve injury, bleeding, or pneumothorax, can be minimized with the use of ultrasound-guided placement. Devices with lower risk for complications (e.g., peripheral IV access) should be prioritized whenever possible."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_b_pm_t49"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"97fc7d",
"children":[
"All intravenous access should be removed as soon as possible to decrease the risk for complications."
]
},
{
"type":"keypoint",
"hlId":"2624b3",
"children":[
"Peripheral intravenous access with a short, wide-bore catheter is the route of choice for rapid volume resuscitation."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_1_10",
"title":{
"__html":"Blood Pressure Support"
},
"titleNode":{
"type":"section-title",
"hlId":"8d4768",
"children":[
"Blood Pressure Support"
]
},
"children":[
{
"type":"p",
"hlId":"5f29fe",
"children":[
"A mean arterial pressure of 65 mm Hg is considered the threshold at which there is sufficient pressure for organ perfusion in most humans. A study of higher (80-85 mm Hg) mean arterial pressures in patients with septic shock demonstrated no improvement in mortality. Blood pressure is usually monitored noninvasively with a blood pressure cuff. An arterial line for continuous monitoring may be more useful than cuff pressures when the systolic blood pressure is less than 90 mm Hg, when frequent measurements are needed (particularly for patients requiring continuous IV medication), or when the cuff readings are unreliable (in patients with morbid obesity, vascular anomalies of the extremities, or other anatomic features limiting cuff accuracy). Assessment of tissue perfusion includes physical examination (skin temperature, mottling, jugular venous distention), measurement of vital signs, and focused cardiac evaluation with tools such as echocardiography and invasive and noninvasive cardiac output monitors. These tools must be applied in the correct clinical scenario to minimize erroneous diagnostic results. Often, physical examination and vital signs alone are sufficient to make diagnostic conclusions. Management of hemodynamic perturbations should focus on the underlying cause of hypotension. For instance, hypotension resulting from deceased preload should be initially treated with volume resuscitation. Support of blood pressure may require the use of vasopressors ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t50",
"wrapId":"8",
"children":[
"Table 50"
]
}
]
},
")"
]
},
". Norepinephrine is the most commonly used agent and has been shown to reduce mortality. However, other agents are available and may be used in specific situations."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_b_pm_t50"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"c9b22b",
"hvc":true,
"children":[
"A mean arterial pressure of 65 mm Hg is considered the threshold at which there is sufficient pressure for organ perfusion in most humans."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_2",
"title":{
"__html":"ICU Complications"
},
"titleNode":{
"type":"section-title",
"hlId":"0bad11",
"children":[
"ICU Complications"
]
},
"children":[
{
"type":"p",
"hlId":"67c6e7",
"children":[
"ICU complications may be classified as early (occurring during the hospitalization) or late (persisting after the critical illness)."
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_2_1",
"title":{
"__html":"ICU-Acquired Weakness"
},
"titleNode":{
"type":"section-title",
"hlId":"d22378",
"children":[
"ICU-Acquired Weakness"
]
},
"children":[
{
"type":"p",
"hlId":"b38e5f",
"children":[
"Between 25% and 100% of critically ill patients develop muscle weakness. Muscle weakness may result from complications involving the nervous system (critical illness polyneuropathy), the muscles themselves (critical illness myopathy), or some combination of both, or it may be nonspecific (ICU-acquired weakness). It may also be related to prolonged neuromuscular blockade. ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t51",
"wrapId":"9",
"children":[
"Table 51"
]
}
]
},
" lists descriptions of types of ICU-acquired weakness. Identified risk factors include sepsis, multisystem organ failure, severe illness, prolonged immobility, and hyperglycemia. Evaluation for ICU-acquired weakness can initially be performed at the bedside, using the Medical Research Council muscle scale—however, electromyogram testing remains the gold standard. ICU-acquired weakness generally improves over weeks to months, but it may persist for years. Strategies to minimize ICU-acquired weakness include aggressive management of critical illness, early mobilization, and management of hyperglycemia."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_b_pm_t51"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"233963",
"children":[
"Strategies to minimize ICU-acquired weakness include aggressive management of critical illness, early mobilization, and management of hyperglycemia."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_2_2",
"title":{
"__html":"Long-Term Cognitive Impairment"
},
"titleNode":{
"type":"section-title",
"hlId":"b62bb7",
"children":[
"Long-Term Cognitive Impairment"
]
},
"children":[
{
"type":"p",
"hlId":"ac419c",
"children":[
"As many as 30% to 80% of patients with critical care illness develop long-term impairment in cognition, which manifests clinically as cognitive impairment. Observations have demonstrated that the level of impairment 1 year after critical illness is similar to mild Alzheimer disease. Although the specific risk factors and interventions related to developing cognitive impairment are not well defined, the development and duration of delirium during the ICU stay appear to be major predictors."
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_2_3",
"title":{
"__html":"Post–Intensive Care Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"9de719",
"children":[
"Post–Intensive Care Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"150723",
"children":[
"Post–intensive care syndrome describes a group of symptoms that present in patients after an episode of critical care. The symptoms have been grouped according to the area that they affect (physical impairment, mental health, and cognitive impairments). Patients with post–intensive care syndrome have increased health care use, increased morbidity and mortality, and impaired quality of life. Post–intensive care syndrome also affects the caregivers and family of the patient; it has been reported that family members experience anxiety, depression, and posttraumatic stress disorder. Current research and interventions are focusing on how to improve recognition, prevention, diagnosis, and management."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s11_3",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Brown SM, Bose S, Banner-Goodspeed V, et al; Addressing Post Intensive Care Syndrome 01 (APICS-01) study team. Approaches to addressing post-intensive care syndrome among intensive care unit survivors. A narrative review. Ann Am Thorac Soc. 2019;16:947-956. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31162935",
"target":"_blank"
},
"children":[
"PMID: 31162935"
]
},
" doi:10.1513/AnnalsATS.201812-913FR"
]
},
{
"type":"reference",
"children":[
"Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825-e873. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30113379",
"target":"_blank"
},
"children":[
"PMID: 30113379"
]
},
" doi:10.1097/CCM.0000000000003299"
]
},
{
"type":"reference",
"children":[
"Girard TD, Alhazzani W, Kress JP, et al; ATS/CHEST Ad Hoc Committee on Liberation from Mechanical Ventilation in Adults. An official American Thoracic Society/American College of Chest Physicians clinical practice guideline: liberation from mechanical ventilation in critically ill adults. Rehabilitation protocols, ventilator liberation protocols, and cuff leak tests. Am J Respir Crit Care Med. 2017;195:120-133. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27762595",
"target":"_blank"
},
"children":[
"PMID: 27762595"
]
},
" doi:10.1164/rccm.201610-2075ST"
]
},
{
"type":"reference",
"children":[
"Neufeld KJ, Needham DM, Oh ES, et al. Antipsychotics for the prevention and treatment of delirium. Comparative Effectiveness Review No. 219. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2015-00006-I-2.) AHRQ Publication No. 19-EHC019-EF. Rockville, MD: Agency for Healthcare Research and Quality; September 2019. doi:10.23970/AHRQEPCCER219"
]
},
{
"type":"reference",
"children":[
"Ouellette DR, Patel S, Girard TD, et al. Liberation from mechanical ventilation in critically ill adults: An official American College of Chest Physicians/American Thoracic Society clinical practice guideline: inspiratory pressure augmentation during spontaneous breathing trials, orotocols minimizing sedation, and noninvasive ventilation immediately after extubation. Chest. 2017;151:166-180. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27818331",
"target":"_blank"
},
"children":[
"PMID: 27818331"
]
},
" doi:10.1016/j.chest.2016.10.036"
]
},
{
"type":"reference",
"children":[
"Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28860265",
"target":"_blank"
},
"children":[
"PMID: 28860265"
]
},
" doi:10.1183/13993003.02426-2016"
]
},
{
"type":"reference",
"children":[
"Rochwerg B, Einav S, Chaudhuri D, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020;46:2226-2237. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33201321",
"target":"_blank"
},
"children":[
"PMID: 33201321"
]
},
" doi:10.1007/s00134-020-06312-y"
]
},
{
"type":"reference",
"children":[
"Taylor BE, McClave SA, Martindale RG, et al; Society of Critical Care Medicine. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. 2016;44:390-438. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26771786",
"target":"_blank"
},
"children":[
"PMID: 26771786"
]
},
" doi:10.1097/CCM.0000000000001525"
]
},
{
"type":"reference",
"children":[
"Thille AW, Muller G, Gacouin A, et al; HIGH-WEAN Study Group and the REVA Research Network. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: A randomized clinical trial. JAMA. 2019;322:1465-1475. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31577036",
"target":"_blank"
},
"children":[
"PMID: 31577036"
]
},
" doi:10.1001/jama.2019.14901"
]
},
{
"type":"reference",
"children":[
"Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31907223",
"target":"_blank"
},
"children":[
"PMID: 31907223"
]
},
" doi:10.1136/bmj.l6722"
]
},
{
"type":"reference",
"children":[
"Zorowitz RD. ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management. Chest. 2016;150:966-971. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27312737",
"target":"_blank"
},
"children":[
"PMID: 27312737"
]
},
" doi:10.1016/j.chest.2016.06.006"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_pm_t43":{
"id":"mk19_b_pm_t43",
"number":43,
"bookId":"pm",
"title":{
"__html":"Summary of Analgesia and Sedation Recommendations for Critical Care Patients"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"2811bd",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 43. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t43"
}
]
},
"Summary of Analgesia and Sedation Recommendations for Critical Care Patients"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccaa79",
"class":"col hd l",
"children":[
"Analgesia Recommendations"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4dd49b",
"class":"cell txt l",
"children":[
"Nonpharmacologic"
]
},
" ",
{
"type":"p",
"hlId":"7937a2",
"class":"cell txt li",
"children":[
"Music therapy"
]
},
" ",
{
"type":"p",
"hlId":"baa154",
"class":"cell txt li",
"children":[
"Local cold therapy for procedures"
]
},
" ",
{
"type":"p",
"hlId":"cf44f3",
"class":"cell txt li",
"children":[
"Massage therapy"
]
},
" ",
{
"type":"p",
"hlId":"c60dd2",
"class":"cell txt li",
"children":[
"Daily sedation interruption"
]
},
" ",
{
"type":"p",
"hlId":"b556ed",
"class":"cell txt li",
"children":[
"Relaxation therapy"
]
},
" ",
{
"type":"p",
"hlId":"c73792",
"class":"cell txt li",
"children":[
"Involve family"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c8671",
"class":"cell txt l",
"children":[
"Pharmacologic"
]
},
" ",
{
"type":"p",
"hlId":"584ec2",
"class":"cell txt li",
"children":[
"Opiates remain as the mainstay therapy"
]
},
" ",
{
"type":"p",
"hlId":"f88b33",
"class":"cell txt li",
"children":[
"Multimodal therapy (nonpharmacologic and nonopiate)"
]
},
" ",
{
"type":"p",
"hlId":"d567a5",
"class":"cell txt li",
"children":[
"Consider opiate reduction strategies"
]
},
" ",
{
"type":"p",
"hlId":"34886a",
"class":"cell txt lii",
"children":[
"Adjunct acetaminophen"
]
},
" ",
{
"type":"p",
"hlId":"79d2a5",
"class":"cell txt lii",
"children":[
"Adjunct low-dose ketamine for postsurgical patients"
]
},
" ",
{
"type":"p",
"hlId":"76e27b",
"class":"cell txt lii",
"children":[
"Adjunct gabapentin, carbamazepine, or pregabalin for nonneuropathic pain"
]
},
" ",
{
"type":"p",
"hlId":"9af420",
"class":"cell txt li",
"children":[
"Preprocedural pain management with opiate or NSAID"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a17129",
"class":"col hd l",
"children":[
"Sedation Recommendations"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bcbc47",
"class":"cell txt l",
"children":[
"Use light sedation rather than deep sedation in mechanically ventilated patients"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"149752",
"class":"cell txt l",
"children":[
"Use sedation protocols"
]
},
" ",
{
"type":"p",
"hlId":"74667c",
"class":"cell txt li",
"children":[
"Nurse-driven protocol"
]
},
" ",
{
"type":"p",
"hlId":"c60dd2",
"class":"cell txt li",
"children":[
"Daily sedation interruption"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4f327",
"class":"cell txt l",
"children":[
"Favor use of propofol or dexmedetomidine over benzodiazepines"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6a8e6c",
"class":"cell txt l",
"children":[
"Use an objective scale to titrate sedation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a7f401",
"class":"cell txt l",
"children":[
"Use a bispectral index monitor to assess sedation when scales cannot be used (e.g., neuromuscular blockers)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"Data from Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825-e873. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30113379",
"target":"_blank"
},
"children":[
"PMID: 30113379"
]
},
" doi:10.1097/CCM.0000000000003299"
]
]
},
"mk19_b_pm_t44":{
"id":"mk19_b_pm_t44",
"number":44,
"bookId":"pm",
"title":{
"__html":"ABCDEF Care Bundle for Managing Delirium in the ICU"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"5f5e6c",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 44. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t44"
}
]
},
"ABCDEF Care Bundle for Managing Delirium in the ICU"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b04c95",
"class":"cell txt l",
"children":[
"A:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"844804",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"A"
]
},
"ssess, prevent, and manage pain"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b355ef",
"class":"cell txt l",
"children":[
"B:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e7318a",
"class":"cell txt l",
"children":[
"Perform ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"B"
]
},
"oth SAT and SBT"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7aa32",
"class":"cell txt l",
"children":[
"C:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"08ff9c",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"C"
]
},
"hoice of sedation and analgesia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d84485",
"class":"cell txt l",
"children":[
"D:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e023fb",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"D"
]
},
"elirium: assessment, prevention, and management"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"be292f",
"class":"cell txt l",
"children":[
"E:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"82fff5",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"E"
]
},
"arly mobility and exercise"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"436b49",
"class":"cell txt l",
"children":[
"F:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9415f",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"F"
]
},
"amily engagement and empowerment"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"SAT = spontaneous awakening trial; SBT= spontaneous breathing trial."
]
]
},
"mk19_b_pm_t45":{
"id":"mk19_b_pm_t45",
"number":45,
"bookId":"pm",
"title":{
"__html":"ICU Care Bundles"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"2d6899",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 45. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t45"
}
]
},
"ICU Care Bundles"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a4032",
"class":"col hd l",
"children":[
"Ventilator-Associated Pneumonia",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f26a8",
"class":"cell txt l",
"children":[
"Head of bed elevated at least 30 degrees"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ea51e",
"class":"cell txt l",
"children":[
"Daily sedation interruption and assessment of readiness to extubate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5f0cb",
"class":"cell txt l",
"children":[
"Endotracheal tubes with subglottic suction"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"477b32",
"class":"cell txt l",
"children":[
"Early exercise or mobilization for physical conditioning"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fbcb6d",
"class":"cell txt l",
"children":[
"Change ventilator circuits only if malfunctioning or visibly soiled"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b41998",
"class":"col hd l",
"children":[
"Central Line–Associated Bloodstream Infections",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24c88f",
"class":"cell txt l",
"children":[
"Hand hygiene"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051465",
"class":"cell txt l",
"children":[
"Maximal barrier precautions"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bae19a",
"class":"cell txt l",
"children":[
"Chlorhexidine skin antisepsis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3e5df",
"class":"cell txt l",
"children":[
"Avoid femoral access"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f7fd0",
"class":"cell txt l",
"children":[
"Daily review of line necessity"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"106e7c",
"class":"col hd l",
"children":[
"Sepsis",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d99acf",
"class":"cell txt l",
"children":[
"1-hour bundle:"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"74e92a",
"class":"cell txt li",
"children":[
"Measure lactate level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"62d613",
"class":"cell txt li",
"children":[
"Obtain blood cultures before antibiotics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"380323",
"class":"cell txt li",
"children":[
"Administer broad-spectrum antibiotics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4eee7a",
"class":"cell txt li",
"children":[
"Administer 30 mL/kg crystalloids for hypotension or lactate ≥4 mEq/L (4 mmol/L)"
]
},
" ",
{
"type":"p",
"hlId":"a6280f",
"class":"cell txt li",
"children":[
"Use vasopressors if no response to fluids; keep MAP above 65 mm Hg"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"MAP = mean arterial blood pressure, calculated as [(2 × diastolic) + systolic]/3."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Recommendations based on Klompas M, Branson R, Eichenwald EC, et al; Society for Healthcare Epidemiology of America (SHEA). Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:915-36. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25026607",
"target":"_blank"
},
"children":[
"PMID: 25026607"
]
},
" doi:10.1086/677144"
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Recommendations from the Institute for Healthcare Improvement."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Recommendations based on Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update [Editorial]. Intensive Care Med. 2018;44:925-928. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29675566",
"target":"_blank"
},
"children":[
"PMID: 29675566"
]
},
" doi:10.1007/s00134-018-5085-0"
]
]
},
"mk19_b_pm_t46":{
"id":"mk19_b_pm_t46",
"number":46,
"bookId":"pm",
"title":{
"__html":"Modes of Noninvasive Positive Pressure Ventilation"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"c8f985",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 46. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t46"
}
]
},
"Modes of Noninvasive Positive Pressure Ventilation"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"650be6",
"class":"col hd l",
"children":[
"Mode"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"864085",
"class":"col hd l",
"children":[
"Function"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10db49",
"class":"col hd l",
"children":[
"Physiologic Effects"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b670b8",
"class":"col hd l",
"children":[
"Indications"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58e5bc",
"class":"cell txt l",
"children":[
"CPAP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b1ad2b",
"class":"cell txt l",
"children":[
"Applies and maintains a constant airway pressure throughout the respiratory cycle"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b8d40",
"class":"cell txt l",
"children":[
"Maintains patent airway in the setting of obstructive sleep apnea, increases functional residual capacity, increases mean airway pressure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0bf538",
"class":"cell txt l",
"children":[
"Obstructive sleep apnea"
]
},
" ",
{
"type":"p",
"hlId":"a4057c",
"class":"cell txt l",
"children":[
"Pulmonary edema"
]
},
" ",
{
"type":"p",
"hlId":"a90d63",
"class":"cell txt l",
"children":[
"Excessive dynamic airway collapse"
]
},
" ",
{
"type":"p",
"hlId":"a23c1d",
"class":"cell txt l",
"children":[
"Preintubation"
]
},
" ",
{
"type":"p",
"hlId":"29539e",
"class":"cell txt l",
"children":[
"Postextubation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3f6bf",
"class":"cell txt l",
"children":[
"BPAP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e692b4",
"class":"cell txt l",
"children":[
"Applies two different levels of airway pressure: IPAP and EPAP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"125018",
"class":"cell txt l",
"children":[
"Same as CPAP, but also decreases work of breathing and augments tidal volume"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b59535",
"class":"cell txt l",
"children":[
"COPD exacerbation"
]
},
" ",
{
"type":"p",
"hlId":"cfe09a",
"class":"cell txt l",
"children":[
"Obesity hypoventilation syndrome"
]
},
" ",
{
"type":"p",
"hlId":"bfbced",
"class":"cell txt l",
"children":[
"Neuromuscular diseases"
]
},
" ",
{
"type":"p",
"hlId":"fb2e7f",
"class":"cell txt l",
"children":[
"Time-limited trial in selected “do not intubate” patients with clear goals of care"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2adc78",
"class":"cell txt l",
"children":[
"BPAP with S/T mode"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8efdcb",
"class":"cell txt l",
"children":[
"BPAP with a minimum set respiration rate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"380c0d",
"class":"cell txt l",
"children":[
"In case of apnea, continues to deliver breaths"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ac868",
"class":"cell txt l",
"children":[
"Hypoventilation, central apneas"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"BPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; EPAP = expiratory positive airway pressure; IPAP = inspiratory positive airway pressure; S/T = spontaneous/timed."
]
]
},
"mk19_b_pm_t47":{
"id":"mk19_b_pm_t47",
"number":47,
"bookId":"pm",
"title":{
"__html":"Most Frequently Used Ventilator Modes"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9f9443",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 47. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t47"
}
]
},
"Most Frequently Used Ventilator Modes"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28437f",
"class":"col hd l",
"children":[
"Common Name"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bbfce1",
"class":"col hd l",
"children":[
"Mode Classification"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ad3885",
"class":"col hd l",
"children":[
"Breath Control Variable"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cdc53a",
"class":"col hd l",
"children":[
"Breath Sequence"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50c488",
"class":"col hd l",
"children":[
"Targeting Scheme"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93932b",
"class":"col hd l",
"children":[
"Characteristics"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45bb2f",
"class":"cell txt l",
"children":[
"Volume control assist/control"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4e9883",
"class":"cell txt l",
"children":[
"VC-CMVs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2d73de",
"class":"cell txt l",
"children":[
"VC: The ventilator controls the flow (volume) during the mandatory breath. If the patient's effort, lung compliance, or resistance changes, the ventilator will still deliver the set tidal volume."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a99046",
"class":"cell txt l",
"children":[
"CMV: All breaths are mandatory. The patient may or may not trigger the breath, but the ventilator always ends (cycles) the breath when the tidal volume is delivered."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5d820",
"class":"cell txt l",
"children":[
"Set-point, s: The operator sets all parameters of the breath (flow waveform, flow rate, and volume). The ventilator does not adjust to the patient's effort or change in lung characteristics."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"afa4b0",
"class":"cell txt l",
"children":[
"Ensures minimum minute ventilation"
]
},
" ",
{
"type":"p",
"hlId":"7f49cf",
"class":"cell txt l",
"children":[
"Ability to limit tidal volume delivered"
]
},
" ",
{
"type":"p",
"hlId":"16952c",
"class":"cell txt l",
"children":[
"Least likely to allow comfort for patient because of limitation in flow"
]
},
" ",
{
"type":"p",
"hlId":"1fcf55",
"class":"cell txt l",
"children":[
"Serves the goal of safety"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0bced8",
"class":"cell txt l",
"children":[
"Pressure control assist/control"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"49682d",
"class":"cell txt l",
"children":[
"PC-CMVs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a15459",
"class":"cell txt l",
"children":[
"PC: The ventilator controls the pressure during the mandatory breath. If the patient's effort, lung compliance, or resistance changes, the ventilator will still deliver the set inspiratory pressure (but the tidal volume delivered will change)."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e5531",
"class":"cell txt l",
"children":[
"CMV: All breaths are mandatory. The patient may or may not trigger the breath, but the ventilator always ends the breath when the preset inspiratory time elapses."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18410f",
"class":"cell txt l",
"children":[
"Set-point, s: The operator sets all parameters of the breath (inspiratory pressure and inspiratory time). The ventilator does not adjust to the patient's effort or change in lung characteristics."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8f212",
"class":"cell txt l",
"children":[
"Ensures pressure will not rise above a set limit"
]
},
" ",
{
"type":"p",
"hlId":"ac9755",
"class":"cell txt l",
"children":[
"Tidal volume is dependent on patient effort, lung compliance, and resistance"
]
},
" ",
{
"type":"p",
"hlId":"7d538c",
"class":"cell txt l",
"children":[
"Serves the goal of safety (if tidal volume within range)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1afbc9",
"class":"cell txt l",
"children":[
"Pressure support, continuous positive airway pressure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fbfe6d",
"class":"cell txt l",
"children":[
"PC-CSVs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36af0a",
"class":"cell txt l",
"children":[
"PC: The ventilator controls the pressure during the breath."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"35ab5d",
"class":"cell txt l",
"children":[
"CSV: All breaths are spontaneous. The patient triggers and cycles the breath."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b3eb57",
"class":"cell txt l",
"children":[
"Set-point, s: The operator sets all parameters of the breath (inspiratory pressure). The ventilator delivers the breath and does not adjust to the patient's effort or change in lung characteristics."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44db54",
"class":"cell txt l",
"children":[
"Patient determines size and timing of breaths"
]
},
" ",
{
"type":"p",
"hlId":"f26c25",
"class":"cell txt l",
"children":[
"Serves the goal of comfort, as it allows synchrony with patient"
]
},
" ",
{
"type":"p",
"hlId":"b6bdd0",
"class":"cell txt l",
"children":[
"Can be used to assess extubation readiness"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b880e3",
"class":"cell txt l",
"children":[
"Synchronized intermittent mandatory ventilation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"793f7b",
"class":"cell txt l",
"children":[
"PC-IMVs,s or VC-IMVs,s"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"daadc3",
"class":"cell txt l",
"children":[
"PC or VC: The mandatory breaths can be set to be volume or pressure controlled, not both."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"236ca2",
"class":"cell txt l",
"children":[
"IMV: Preset mandatory breaths are delivered by the ventilator at a minimum set rate. Spontaneous breaths are permitted in between mandatory breaths. The triggering of the mandatory breath will be coordinated with the patient if the inspiratory effort occurs close to the scheduled time trigger."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"723da2",
"class":"cell txt l",
"children":[
"Set-point, s: One “s” refers to the mandatory breath and the other to the spontaneous breath. Generally, all spontaneous breaths in IMV are pressure supported (PC-CSVs)."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f0aafc",
"class":"cell txt l",
"children":[
"Provides a minimum set amount of mandatory breaths"
]
},
" ",
{
"type":"p",
"hlId":"978bfd",
"class":"cell txt l",
"children":[
"Allows spontaneous breaths"
]
},
" ",
{
"type":"p",
"hlId":"fa885a",
"class":"cell txt l",
"children":[
"Serves the goal of safety, as it allows a minimum minute ventilation"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CMV = continuous mandatory ventilation; CSV = continuous spontaneous ventilation; IMV = intermittent mandatory ventilation; PC = pressure controlled; s = set-point; VC = volume controlled."
]
]
},
"mk19_b_pm_t48":{
"id":"mk19_b_pm_t48",
"number":48,
"bookId":"pm",
"title":{
"__html":"Common Criteria for Spontaneous Breathing Trials and Extubation<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"23f9c4",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 48. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t48"
}
]
},
"Common Criteria for Spontaneous Breathing Trials and Extubation",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"782d66",
"class":"col hd l",
"children":[
"Criteria to Perform SBT"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"da88e4",
"class":"cell txt l",
"children":[
"Cause of respiratory failure improved"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"373284",
"class":"cell txt l",
"children":[
"F",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"IO"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" ≤40% and PEEP ≤5-8 cm H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"O"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21c5e3",
"class":"cell txt l",
"children":[
"pH >7.25"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72f353",
"class":"cell txt l",
"children":[
"Hemodynamic stability"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"459ed5",
"class":"cell txt l",
"children":[
"Able to spontaneously breathe"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a30a3",
"class":"col hd l",
"children":[
"Criteria to Pass SBT—At Least 30 Minutes Without the Following"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bbad93",
"class":"cell txt l",
"children":[
"Clinical evidence of respiratory distress"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89f0c0",
"class":"cell txt li",
"children":[
"SpO",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" <90%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ab4d0e",
"class":"cell txt li",
"children":[
"Respiration rate >35/min"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"201a82",
"class":"cell txt l",
"children":[
"New arrhythmias"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"db3d58",
"class":"cell txt l",
"children":[
"Tachycardia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3964c7",
"class":"cell txt l",
"children":[
"Hypotension or hypertension"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"708194",
"class":"col hd l",
"children":[
"Additional Considerations Before Extubation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5fa169",
"class":"cell txt l",
"children":[
"Quantity of secretions: need for frequent suctioning"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3da7d",
"class":"cell txt l",
"children":[
"Adequacy of cough"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a54675",
"class":"cell txt l",
"children":[
"Altered mental status"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"PEEP = positive end-expiratory pressure; SBT = spontaneous breath trial; SpO",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" = peripheral arterial oxygen saturation."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"These criteria may differ between institutions."
]
]
},
"mk19_b_pm_t49":{
"id":"mk19_b_pm_t49",
"number":49,
"bookId":"pm",
"title":{
"__html":"Types of Central Venous Access"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"eef8f5",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 49. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t49"
}
]
},
"Types of Central Venous Access"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1fa27",
"class":"col hd l",
"children":[
"Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b670b8",
"class":"col hd l",
"children":[
"Indications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e02d2a",
"class":"col hd l",
"children":[
"Duration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f0bd52",
"class":"col hd l",
"children":[
"Potential Complications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a7698",
"class":"col hd l",
"children":[
"Contraindications"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7598e6",
"class":"cell txt l",
"children":[
"Peripherally inserted central venous catheter"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45c436",
"class":"cell txt l",
"children":[
"Delivery of potentially caustic medications such as vasoactive agents, sedatives, or antibiotics; central venous access"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"48eb11",
"class":"cell txt l",
"children":[
"A few days to 1 year"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"efe591",
"class":"cell txt l",
"children":[
"Low risk overall for pneumothorax; reduced infection risk compared with nontunneled catheter; risk for clot formation or occlusion resulting from smaller vessel diameter"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"258c60",
"class":"cell txt l",
"children":[
"Current or pending dialysis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd75ec",
"class":"cell txt l",
"children":[
"Temporary nontunneled"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ea832",
"class":"cell txt l",
"children":[
"Same as peripherally inserted central venous catheter; short-term dialysis, central venous pressure monitoring"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23d86a",
"class":"cell txt l",
"children":[
"Infection risk increased after 7 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"52f0b1",
"class":"cell txt l",
"children":[
"Infection, site-specific complications such as pneumothorax for subclavian or low internal jugular approach"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9733d1",
"class":"cell txt l",
"children":[
"Long-term tunneled"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1edce3",
"class":"cell txt l",
"children":[
"Long-term TPN, chemotherapy, long-term antibiotics, dialysis; tunneled Dacron cuff or other fabric allows tissue adherence to reduce infection and dislodgement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2502c8",
"class":"cell txt l",
"children":[
"More than 6 weeks"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cc282a",
"class":"cell txt l",
"children":[
"Infection, same risks as nontunneled catheter during placement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d63d78",
"class":"cell txt l",
"children":[
"Ports or totally implanted"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"70801a",
"class":"cell txt l",
"children":[
"Long-term intermittent access such as chemotherapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2502c8",
"class":"cell txt l",
"children":[
"More than 6 weeks"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"20989b",
"class":"cell txt l",
"children":[
"Lowest risk for infection, but more difficult to implant with more costs; hidden extravasation beneath skin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5a184",
"class":"cell txt l",
"children":[
"Intraosseous (tibia or humeral head [adults])"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c851c9",
"class":"cell txt l",
"children":[
"When IV access otherwise not attainable in emergent setting"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f48dba",
"class":"cell txt l",
"children":[
"About 24 hours"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"12b27d",
"class":"cell txt l",
"children":[
"Low risk for infection; flow rates may be slower; if pain with infusion, can use 2% preservative-free lidocaine injected slowly to control it"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0f0c8d",
"class":"cell txt l",
"children":[
"Do not place in a bone with a fracture, in a patient with a diagnosis of osteoporosis, or after a recent (24-48 h) intraosseous access attempt"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"IV = intravenous; TPN = total parenteral nutrition."
]
]
},
"mk19_b_pm_t50":{
"id":"mk19_b_pm_t50",
"number":50,
"bookId":"pm",
"title":{
"__html":"Selection of Vasopressors and Inotropes"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"3c2f1e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 50. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t50"
}
]
},
"Selection of Vasopressors and Inotropes"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353bd6",
"class":"col hd l",
"children":[
"Medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"709d81",
"class":"col hd l",
"children":[
"Type of Shock"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f36245",
"class":"col hd l",
"children":[
"Receptor Target"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f449d8",
"class":"col hd l",
"children":[
"Primary Effect"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8413c6",
"class":"col hd l",
"children":[
"Comments"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"baf153",
"class":"cell txt l",
"children":[
"Angiotensin II"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1e5cd4",
"class":"cell txt l",
"children":[
"Distributive"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"20343a",
"class":"cell txt l",
"children":[
"AT II"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b0fa0",
"class":"cell txt l",
"children":[
"↑ SVR"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"966f41",
"class":"cell txt l",
"children":[
"Role still being defined; concern for increase in thrombotic events"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9ff335",
"class":"cell txt l",
"children":[
"Dobutamine (not a vasopressor)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"978dcf",
"class":"cell txt l",
"children":[
"Cardiogenic"
]
},
" ",
{
"type":"p",
"hlId":"1e5cd4",
"class":"cell txt l",
"children":[
"Distributive"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a12853",
"class":"cell txt l",
"children":[
"β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bea02c",
"class":"cell txt l",
"children":[
"↑ Inotropy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e31607",
"class":"cell txt l",
"children":[
"First choice for cardiogenic shock without hypotension"
]
},
" ",
{
"type":"p",
"hlId":"b3ec73",
"class":"cell txt l",
"children":[
"May be added to norepinephrine for septic shock with depressed cardiac function"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d64d44",
"class":"cell txt l",
"children":[
"Dopamine (high-dose)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"978dcf",
"class":"cell txt l",
"children":[
"Cardiogenic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ad4b53",
"class":"cell txt l",
"children":[
"D, α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"964941",
"class":"cell txt l",
"children":[
"↑ SVR, ↑ inotropy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a43cfb",
"class":"cell txt l",
"children":[
"Associated with increased mortality compared with norepinephrine in distributive shock; use only in cases of severe bradycardia in septic shock"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e0f3a",
"class":"cell txt l",
"children":[
"Dopamine (low-dose)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"978dcf",
"class":"cell txt l",
"children":[
"Cardiogenic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf891d",
"class":"cell txt l",
"children":[
"D, β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f2f01",
"class":"cell txt l",
"children":[
"↑ Inotropy, ↑ HR"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"90e036",
"class":"cell txt l",
"children":[
"Not recommended to augment renal blood flow"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39e38c",
"class":"cell txt l",
"children":[
"Epinephrine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"978dcf",
"class":"cell txt l",
"children":[
"Cardiogenic"
]
},
" ",
{
"type":"p",
"hlId":"1e5cd4",
"class":"cell txt l",
"children":[
"Distributive"
]
},
" ",
{
"type":"p",
"hlId":"77c388",
"class":"cell txt l",
"children":[
"Hypovolemic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a1a4d",
"class":"cell txt l",
"children":[
"α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"964941",
"class":"cell txt l",
"children":[
"↑ SVR, ↑ inotropy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0dd136",
"class":"cell txt l",
"children":[
"First choice anaphylactic (distributive) shock"
]
},
" ",
{
"type":"p",
"hlId":"150836",
"class":"cell txt l",
"children":[
"May be added to norepinephrine and vasopressin in persistent septic (distributive) shock"
]
},
" ",
{
"type":"p",
"hlId":"9ca371",
"class":"cell txt l",
"children":[
"May be used as a single agent in septic shock with depressed cardiac function"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f7ac0c",
"class":"cell txt l",
"children":[
"Norepinephrine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"978dcf",
"class":"cell txt l",
"children":[
"Cardiogenic"
]
},
" ",
{
"type":"p",
"hlId":"1e5cd4",
"class":"cell txt l",
"children":[
"Distributive"
]
},
" ",
{
"type":"p",
"hlId":"77c388",
"class":"cell txt l",
"children":[
"Hypovolemic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"71a993",
"class":"cell txt l",
"children":[
"α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"964941",
"class":"cell txt l",
"children":[
"↑ SVR, ↑ inotropy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"450ba6",
"class":"cell txt l",
"children":[
"First choice in cardiogenic, distributive, and hypovolemic shock"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a1c6d",
"class":"cell txt l",
"children":[
"Vasopressin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1e5cd4",
"class":"cell txt l",
"children":[
"Distributive"
]
},
" ",
{
"type":"p",
"hlId":"77c388",
"class":"cell txt l",
"children":[
"Hypovolemic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"520656",
"class":"cell txt l",
"children":[
"V"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b0fa0",
"class":"cell txt l",
"children":[
"↑ SVR"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a839b",
"class":"cell txt l",
"children":[
"May be added to norepinephrine in persistent septic (distributive) shock; no role in other shock states"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AT II = angiotensin type II; HR = heart rate; SVR = systemic vascular resistance."
]
]
},
"mk19_b_pm_t51":{
"id":"mk19_b_pm_t51",
"number":51,
"bookId":"pm",
"title":{
"__html":"Definitions and Characteristics of ICU-Acquired Weakness"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b69b27",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 51. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t51"
}
]
},
"Definitions and Characteristics of ICU-Acquired Weakness"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d22378",
"class":"col hd l",
"children":[
"ICU-Acquired Weakness"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a727a2",
"class":"cell txt l",
"children":[
"Clinically detected weakness with no explanation other than the critical illness"
]
},
" ",
{
"type":"p",
"hlId":"b8c35c",
"class":"cell txt l",
"children":[
"Proximal and distal symmetrical flaccid weakness with sparing of cranial nerves"
]
},
" ",
{
"type":"p",
"hlId":"a842a8",
"class":"cell txt l",
"children":[
"Often failure to wean from mechanical ventilation is the first indication of weakness"
]
},
" ",
{
"type":"p",
"hlId":"c34e67",
"class":"cell txt l",
"children":[
"Diagnosis of exclusion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf401d",
"class":"col hd l",
"children":[
"Critical Illness Polyneuropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"20a4d5",
"class":"cell txt l",
"children":[
"ICU-acquired weakness with electrophysiological evidence of axonal polyneuropathy"
]
},
" ",
{
"type":"p",
"hlId":"c66ea2",
"class":"cell txt l",
"children":[
"Quadriparesis or quadriplegia, decreased muscle tone, sparing of facial muscles; deep tendon reflexes decreased"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c9a837",
"class":"col hd l",
"children":[
"Critical Illness Myopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba5b98",
"class":"cell txt l",
"children":[
"ICU-acquired weakness with electrophysiological or histological evidence of myopathy"
]
},
" ",
{
"type":"p",
"hlId":"8899fd",
"class":"cell txt l",
"children":[
"Examination is similar to critical illness polyneuropathy; new sensory loss is suggestive; creatinine kinase may be elevated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89115c",
"class":"col hd l",
"children":[
"Critical Illness Neuromyopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01c325",
"class":"cell txt l",
"children":[
"Coexistence of critical Illness polyneuropathy and critical illness myopathy"
]
},
" ",
{
"type":"p",
"hlId":"a5bb76",
"class":"cell txt l",
"children":[
"Mixed features; perhaps most prevalent form"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b2c8f",
"class":"col hd l",
"children":[
"Prolonged Neuromuscular Blockade"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff10b4",
"class":"cell txt l",
"children":[
"Prolonged effects in patients with renal failure, liver failure, hypermagnesemia"
]
},
" ",
{
"type":"p",
"hlId":"68489c",
"class":"cell txt l",
"children":[
"Flaccid areflexic quadriplegia with cranial nerve involvement"
]
},
" ",
{
"type":"p",
"hlId":"671bf6",
"class":"cell txt l",
"children":[
"Repetitive nerve stimulation shows decremental response"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}